• 1
    Loehrer PJ Sr, Einhorn LH, Elson PJ et al. A randomized comparison of cisplation alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 1992; 10: 106673
  • 2
    Vale C. Neoadjuvant chemotherapy in invasive bladder cancer. a systematic review and meta-analysis. Lancet 2003; 361: 192734
  • 3
    Leahy MG, Brown J, Jones WG, Kelly JDG, Prescott S, Roberts T. The EMI study. A regional feasibility study for a randomised trial of adjuvant chemotherapy after definitive treatment for TCC of the bladder. BJU Int 2002; 90 (Suppl. 1): 4 (Abstract 31)
  • 4
    Bellmunt J, De Wit R, Albiol S, Tabernero J, Albanell J, Baselga J. New drugs and new approaches in metastatic bladder cancer. Crit Rev Oncol Hematol 2003; 47: 195206
  • 5
    Hussain SA, James ND. The systemic treatment of advanced and metastatic bladder cancer. Lancet Oncol 2003; 4: 48996
  • 6
    Tobias JS, Ball D. Synchronous chemoradiation for squamous carcinomas. BMJ 2001; 322: 8768
  • 7
    Coppin CM, Gospodarowicz MK, James K et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1996; 14: 29017
  • 8
    UKCCR Anal Cancer Trial Working Party. Epidermoid anal cancer. Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996; 348: 104954
  • 9
    Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993; 25: 7919